Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

NCT03081858 is registered in ClinicalTrials.gov with Lipac Oncology LLC as lead sponsor.

NCT NCT03081858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03081858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2a Pilot Study of Intravesical TSD-001 for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Lead sponsor
Lipac Oncology LLC
Phase
Phase 1/2
Overall status
Completed
Start date
May 17, 2018
Completion date
August 5, 2021
Enrollment
15 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, bladder cancer cell transitional, non-muscle invasive bladder cancer, transitional cell carcinoma of the bladder, urinary bladder, urinary bladder diseases, urinary bladder neoplasms, urogenital neoplasms, urologic diseases, urologic neoplasms